K. Higashitani

Comprehensive immunological analyses of colorectal cancer patients in the phase I/II study of quickly matured dendritic cell vaccine pulsed with carcinoembryonic antigen peptide

N. Hayashi, A. Kasahara, N. Hiramatsu, 2011, Cancer Immunology, Immunotherapy.

Enhanced ability of regulatory T cells in chronic hepatitis C patients with persistently normal alanine aminotransferase levels than those with active hepatitis

N. Hayashi, A. Kasahara, N. Hiramatsu, 2009, Journal of viral hepatitis.

Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: A crucial role of CD25−FOXP3− T cells

N. Hayashi, A. Kasahara, N. Hiramatsu, 2012, International journal of cancer.

Human blood dendritic cell antigen 3 (BDCA3)+ dendritic cells are a potent producer of interferon‐λ in response to hepatitis C virus

H. Nagano, N. Hayashi, N. Hiramatsu, 2013, Hepatology.

Dynamics of regulatory T cells and plasmacytoid dendritic cells as immune markers for virological response in pegylated interferon-α and ribavirin therapy for chronic hepatitis C patients

N. Hayashi, A. Kasahara, N. Hiramatsu, 2012, Journal of Gastroenterology.

TIE2‐expressing monocytes as a diagnostic marker for hepatocellular carcinoma correlates with angiogenesis

H. Nagano, N. Hayashi, A. Kasahara, 2013, Hepatology.

Association of enhanced activity of indoleamine 2,3-dioxygenase in dendritic cells with the induction of regulatory T cells in chronic hepatitis C infection

Y. Imai, N. Hayashi, A. Kasahara, 2013, Journal of Gastroenterology.